This product is a recombinant human anti-Hepatitis B virus monoclonal antibody (C2). C2 specifically binds to surface antigen associated with HBV and can be potentially used in the diagnosis and treatment studies of Hepatitis B virus infection. C2 showed significant HBsAg-binding specificity by ELISA using recombinant HBsAg. KD values of antibody C2 to HBsAg is 9.95 nM.
Figure 1 Infection of PHH by HBV genotype A2, B5, C2, and D3, respectively.
HBsAg (green) expression at day 12 was detected by immunofluorescence.
(2018). Hepatitis b virus sensitivity to interferon‐α in hepatocytes is more associated with cellular interferon response than with viral genotype. Hepatology, 67(4).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-102LC | Recombinant Anti-HBsAg Antibody (Fc glycosylation) | ELISA | Mouse antibody |
There are currently no Customer reviews or questions for MRO-440LC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.